Menu
ncarol.com
  • Home
  • Business
  • Financial
  • Health
  • Nyse
  • Yacht Buyer
  • Banking
  • Stocks
  • Finance
ncarol.com

North Carolina: Leading Gene Therapy Company to Invest Over $100 Million in Sanford
ncarol.com/10046557

Trending...
  • VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
  • National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP
  • Dr. Sheel Desai Solomon and Preston Dermatology Continue Awards Streak with Top Honors in 2026 Maggy Awards
Today, Governor Roy Cooper announced that Audentes Therapeutics, a genetic medicines company, will create 209 new jobs in Lee County, investing $109 million to locate a manufacturing facility in Sanford.

"With our powerhouse research centers and highly-skilled workforce, biotech pioneers recognize North Carolina's role as a leader in the life sciences," said Governor Cooper. "Lee County is a perfect fit for Audentes as they seek to become a global leader in genetic medicines."

An Astellas company, Audentes Therapeutics focuses on developing and commercializing innovative genetic medicines that can offer transformative benefits to patients. Audentes will develop a 135,000 square foot, state-of-the-art, large-scale gene therapy manufacturing facility in Sanford. The initial phase of the capital investment is planned to occur over approximately 18 months, with the plant expected to become operational in 2021. The remaining investment will take place over two additional planned expansion phases.

"Our investment in internal large-scale manufacturing has always been a cornerstone of our strategy to develop and ultimately deliver our important genetic medicines to patients as rapidly as possible. This new facility in Sanford will support the next phase of our growth as we establish a robust, global supply chain and expand our therapeutic and geographic scope as a part of the Astellas group of companies," stated Natalie Holles, President and Chief Executive Officer of Audentes. "We are excited to join the vibrant biopharmaceutical research and manufacturing community that the state of North Carolina has established."

More on ncarol.com
  • Claude Riveloux Review 2026: How the $10B Fund Manager Dispels 'Scam' Rumors Through Education
  • Pure Energy Electrical Services, LLC Announces Strong Start to 2026, Reinforcing Customer-First Electrical Service Across Northeast Florida
  • Danholm Collection Launches Boutique Luxury Real Estate Brokerage in Central Florida
  • Sellvia Market Expands Curated Store Portfolio for Dropshipping Sellers
  • Food Journal Magazine Raises the Standard for Restaurant Reviews in Los Angeles

"Audentes Therapeutics is joining one of the nation's top life science clusters," said North Carolina Commerce Secretary Anthony M. Copeland. "North Carolina has the largest biomanufacturing workforce in the nation and a growing concentration of gene therapy scientists, researchers and workers."

The North Carolina Department of Commerce led the state's support for the company's decision.

The average for all new positions could reach up to $83,900. The current average annual wage in Lee County of $41,784.

Audentes' project in North Carolina will be facilitated, in part, by a Job Development Investment Grant (JDIG) approved by the state's Economic Investment Committee earlier today. Over the course of the 12-year term of this grant, the project is estimated to grow the state's economy by nearly $1.4 billion. Using a formula that takes into account the new tax revenues generated by the 209 new jobs, the JDIG agreement authorizes the potential reimbursement to the company of up to $3,725,100, spread over 12 years. State payments only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant's reimbursement payments to a given company.

More on ncarol.com
  • Call for Nominations for the 2027 Paul E Garber First Flight Shrine
  • Williamsville Spa Expands Team to Meet Growing Demand for Professional Facials
  • Pregis Expands Wind Energy Use, Advancing Progress Toward Net Zero by 2040
  • Dr. Sheel Desai Solomon and Preston Dermatology Continue Awards Streak with Top Honors in 2026 Maggy Awards
  • Jack and Sage Acquires Sustainable Apparel Brand Kastlfel, Expanding Premium Logo Wear Across National Parks and Ski Resorts

Because Audentes chose to locate in Lee County, classified by the state's economic tier system as Tier 2, the company's JDIG agreement also calls for moving as much as $414,000 into the state's Industrial Development Fund – Utility Account. The Utility Account helps rural communities finance necessary infrastructure upgrades to attract future business. Even when new jobs are created in a Tier 2 county such as Lee, the new tax revenue generated through JDIG grants helps more economically challenged communities elsewhere in the state. More information on the state's economic tier designations is available here.

"This is an exciting day for Lee County and the City of Sanford because this business is an important part of the biotechnology industry, creating hundreds of jobs and contributing millions of dollars to our local economy," said N.C. Senator Jim Burgin.

"Audentes' new jobs and investment are great wins for the entire state," said N.C. Representative John Sauls. "North Carolina has a strong pipeline of biopharmaceutical talent and a business climate to support their future growth and success."

In addition to N.C. Commerce and the Economic Development Partnership of North Carolina, other key partners in the project include the North Carolina General Assembly, North Carolina Community College System, Lee County, Sanford Area Growth Alliance, City of Sanford, and North Carolina Biotechnology Center.

Filed Under: Government, State

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • New Environmental Thriller "The Star Thrower" Reimagines a Classic Lesson in Individual Impact
  • Summit Appoints Javier Cabeza as Data, AI, and Analytics Practice Lead
  • Interview: Why I Sponsored Carson Ware - The Full Story
  • March Is Skiing's Smartest Buying Window
  • Zeo Health Introduces KidZ Cleanse with Folinic Acid
  • Cancun Airport Transportation Expands Fleet Ahead of Record Passenger Growth at Cancun International Airport
  • Tobu Group's "T-home Series" of Accommodations in Tokyo Just Opened "T-home KEI."
  • Custom Wooden Token Manufacturer Celebrates 10 Years of Helping Brands Stay Top of Mind
  • NaturismRE Launches the NRE Health Institute to Advance Evidence-Informed Public Health Research
  • P-Wave Classics to publish Robert Bage's Hermsprong in three volumes, beginning 12 May
  • Ease Auto Group Inc. & Ease Fleet Repair Service Celebrate Grand Opening Charlotte, North Carolina
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
  • Arcuri Group Announces Long‑Term Partnership with WakeMed Health & Hospitals to Deliver Situational Awareness and De‑escalation Training
  • At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
  • Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
  • VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
  • Atlanta Tech Founder Seeks Clarity on Intellectual Property and Innovation Policy
  • FPTower Inc. nonprofit launches coastal safety raffle fundraiser
  • Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
_catLbl0 _catLbl1

Popular on ncarol.com

  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies - 117
  • Still Using Ice? FrostSkin Reinvents Hydration - 102
  • Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments - 102
  • Blasting Off with Space Sector Companies: Artemis II Manned Moon Mission is Set to Launch: Could $ASTI be on the Same Rocket Ride as $ASTS & $LUNR?
  • François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only
  • Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
  • Diversified Roofing Solutions Strengthens Industry Leadership With Expanded Roofing Services Across South Florida
  • General Relativity Challenged by New Tension Discovered in Dark Siren Cosmology
  • Cold. Clean. Anywhere. Meet FrostSkin
  • Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract

Similar on ncarol.com

  • CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
  • Arcuri Group Announces Long‑Term Partnership with WakeMed Health & Hospitals to Deliver Situational Awareness and De‑escalation Training
  • IDpack v4 Launches: A Major Evolution in Cloud-Based ID Card Issuance
  • CCHR Says Psychiatry's Admission on Antidepressant Withdrawal Comes Far Too Late
  • Integris Composites developing armor for military in Arctic Circle
  • Delay In Federal Disaster Assistance Causing Failure Of Small Business In Disaster Areas
  • When Representation No Longer Reflects the District — Why I'm Voting for Pete Verbica
  • CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
  • Amy Turner Receives 2025 ENPY Partnership Builder Award from The Community Foundation
  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute